Literature DB >> 12128166

Anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin derivatives.

Seshaiah Krishnan Sridhar1, Surendra N Pandeya, James P Stables, Atmakuru Ramesh.   

Abstract

In the present study, anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin were evaluated by maximal electroshock method (MES) and metrazol-induced convulsions (MET) at 30, 100 and 300 mg/kg dose levels. Neurotoxicity of the compounds was also assessed at the same dose levels. Eight compounds of the series exhibited significant anticonvulsant activity at 30 mg/kg dose level. 3-(4-chloro-phenylimino)-5-methyl-1,3-dihydro-indol-2-one (compound 10) was found to be the most potent compound of the series with 87% protection at 100 mg/kg and an ED(50) of 53.61 mg/kg (MET). All the compounds exhibited lesser neurotoxicity compared to phenytoin. All the active compounds showed greater protection than sodium valproate. The essential structural features responsible for interaction with receptor site are established within a suggested pharmacophore.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12128166     DOI: 10.1016/s0928-0987(02)00077-5

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  29 in total

1.  In vivo metabolism of 2-[1'-phenyl-3'-(3-chlorophenyl)-2'-propenylyden]hydrazino-3-methyl-4(3H)-quinazolinone in rats.

Authors:  Bedia Koçyiğit Kaymakçioğlu; Yasemin Aktan; Sibel Süzen; Nesrin Gökhan; Semra Koyunoğlu; Kevser Erol; Akgül Yeşilada; Sevim Rollas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Oct-Dec       Impact factor: 2.441

2.  HPLC analysis of in vivo metabolites of 4-nitrobenzoic acid [(5-nitro-2-thiopheneyl)methylene]hydrazide in rats.

Authors:  Bedia Koçyiğit-Kaymakçioğlu; Seda Unsalan; S Güniz Küçükgüzel; Göksel Sener; Sevim Rollas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Oct-Dec       Impact factor: 2.441

3.  Integrative chemical-biological read-across approach for chemical hazard classification.

Authors:  Yen Low; Alexander Sedykh; Denis Fourches; Alexander Golbraikh; Maurice Whelan; Ivan Rusyn; Alexander Tropsha
Journal:  Chem Res Toxicol       Date:  2013-08-05       Impact factor: 3.739

4.  (Z)-N-Methyl-2-(5-nitro-2-oxoindolin-3-yl-idene)hydrazinecarbothio-amide.

Authors:  Amna Qasem Ali; Naser Eltaher Eltayeb; Siang Guan Teoh; Abdussalam Salhin; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-03

5.  Molecular aspects on the interaction of isatin-3-isonicotinylhydrazone to deoxyribonucleic acid: model for intercalative drug-DNA binding.

Authors:  Soheila Kashanian; Mohammad Mehdi Khodaei; Parvaneh Pakravan; Hadi Adibi
Journal:  Mol Biol Rep       Date:  2011-07-21       Impact factor: 2.742

6.  4-{[(E)-(3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)methyl-idene]amino}-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one.

Authors:  Hoong-Kun Fun; Madhukar Hemamalini; Abdullah M Asiri; Salman A Khan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-09

7.  Synthesis characterization and biological activity study of new schiff and mannich bases and some metal complexes derived from isatin and dithiooxamide.

Authors:  Ahlam J Abdulghani; Nada M Abbas
Journal:  Bioinorg Chem Appl       Date:  2011-05-15       Impact factor: 7.778

8.  Design and Synthesis of Some Novel 4-(4-substituted aryl) Semicarbazones as Anticonvulsant Agents.

Authors:  Anita Singh; C Pande; P Gahtori; S N Pandeya; J P Stables
Journal:  Indian J Pharm Sci       Date:  2010-05       Impact factor: 0.975

9.  (1E,2E)-1,2-Bis[1-(2-methoxy-phen-yl)ethyl-idene]hydrazine.

Authors:  Suchada Chantrapromma; Patcharaporn Jansrisewangwong; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-10-31

10.  (Z)-2-(5-Methyl-2-oxoindolin-3-yl-idene)-N-phenyl-hydrazinecarbothio-amide.

Authors:  Amna Qasem Ali; Naser Eltaher Eltayeb; Siang Guan Teoh; Abdussalam Salhin; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.